Clinical Trial

A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 3, 2026 (before its estimated April 22, 2026 completion). Its status may not reflect the trial's current state.
Summary
A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 Under Fed Conditions in Healthy Adult Male Subjects
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-26.
Trial Details
NCT Number NCT07444385
Lead Sponsor Addpharma Inc.
Conditions Benign Prostatic Hyperplasia
Enrollment 44 participants
Start Date 2026-02-26
Primary Completion 2026-04-22 (estimated)
Study Completion 2026-05-08 (estimated)
Updated on ClinicalTrials.gov 2026-03-03